Nu-Med Plus (NUMD) Total Debt Growth (3y) (2014 - 2026)
Powered by 
Analysis
Nu-Med Plus (NUMD) Total Debt Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -10.56% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 0.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Dec 31, 2025 | -9.38% |
| Sep 30, 2025 | 12.96% |
| Jun 30, 2025 | 18.99% |
| Mar 31, 2025 | 46.20% |
| Dec 31, 2024 | 56.68% |
| Sep 30, 2024 | 71.00% |
| Jun 30, 2024 | 56.68% |
| Mar 31, 2024 | 41.38% |
| Dec 31, 2023 | 50.42% |
| Sep 30, 2023 | -27.23% |
| Jun 30, 2023 | -27.42% |
| Mar 31, 2023 | -25.93% |
| Dec 31, 2022 | -18.05% |
| Sep 30, 2022 | -34.25% |
| Jun 30, 2022 | -37.56% |
| Mar 31, 2022 | -49.23% |
| Dec 31, 2021 | -53.10% |
| Sep 30, 2021 | -56.53% |
| Jun 30, 2021 | -52.71% |